Cargando…
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
Pancreatic cancer is a major health concern worldwide and, despite the attempts at management, the prognosis of patients with metastatic pancreatic cancer remains poor, with a median survival of a few months. The aim of this study was to identify and evaluate clinicopathological factors and elucidat...
Autores principales: | TAS, FARUK, SEN, FATMA, KESKIN, SERKAN, KILIC, LEYLA, YILDIZ, IBRAHIM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916173/ https://www.ncbi.nlm.nih.gov/pubmed/24649248 http://dx.doi.org/10.3892/mco.2013.131 |
Ejemplares similares
-
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy
por: Faruk Aykan, N., et al.
Publicado: (2013) -
Age is a prognostic factor affecting survival in lung cancer patients
por: TAS, FARUK, et al.
Publicado: (2013) -
Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
por: Yildiz, Ibrahim, et al.
Publicado: (2014) -
Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer
por: TAS, FARUK, et al.
Publicado: (2013) -
Prognostic and Predictive Role of Angiogenic Markers in Non- Small Cell Lung Cancer
por: Keskin, Serkan, et al.
Publicado: (2019)